Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Boehringer Ingelheim
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Inclusion\_Criteria
Acute symptomatic deep vein thrombosis (DVT)
Pulmonary embolism (PE) 3-12 months prior to screening, which has been documented by objective testing
You may not be if
Exclusion\_Criteria
Symptomatic DVT or PE at screening Interruption of anticoagulant therapy for 2 or more weeks during the 3-12 months of treatment for the prior VTE.
Patients who in the investigators judgement are perceived as having an excessive risk of bleeding Elevated Aspartate aminotransferase (AST) or Alanine tranminase (ALT) \> 2x ULN
Severe renal impairment (estimated creatinine clearance \<= 30 ml/min)
Clareo Health | Secondary Prevention of Venous Thrombo Embolism (VTE).
